| |
|
|
|
Portola Pharmaceuticals Inc.  
|
|
18.03 0 (0%) |
07-01 16:00 |
|
Open: |
18 |
Pre close: |
18.03 |
Target:
|
21.11
|
|
High: |
18.07 |
Low: |
17.99 |
Resistance:
|
18.07
21.11
|
|
Volume: |
0 |
Market Cap: |
1408M |
Support:
|
17.90
17.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
18.00
 |
MACD |
MACD(12,26):
|
0.44  |
|
MA(20): |
17.95 |
Signal(12,26,9): |
0.61 |
|
MA(100): |
12.51 |
Stochastic Oscillator |
%K(14,3):
|
84.31 |
|
MA(250): |
20.47 |
%D(3): |
86.48 |
|
Average Volume(K) |
3-Month: |
449873
|
52-Week |
High:
|
31.73 |
|
10-Days: |
231678 |
Low: |
5.31 |
|
RSI |
RSI(14):
|
80.86 |
Change(%): |
-30.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.780 |
Return on Equity (ttm) |
-462.3 |
Shares Out. (M) |
78.48 |
|
EPS Est. Current Year |
-4.820 |
Return on Assets (ttm) |
-30.6 |
Shares Float (M) |
73.19 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.53 |
|
EPS Est. Next Quarter |
-1.410 |
Qtrly Rev. Growth |
19.0 |
% Held by Institutions |
105.56 |
|
Forward EPS |
-4.060 |
Gross Profit (p.s.) |
-0.277 |
Shares Short (K) |
12950 |
|
Book Value (p.s.) |
0.920 |
EBITDA (p.s.) |
-2.813 |
P/E |
-4.77 |
|
Sales Per Share |
1.540 |
Qtrly Earnings Growth |
0.00 |
P/BV |
19.60 |
|
Profit Margin |
-232.73 |
Operating Cash Flow
(M) |
-245.39 |
P/S |
11.71 |
|
Operating Margin |
-185.02 |
Levered Free Cash Flow
(M) |
-98.53 |
P/CF |
-5.77 |
|
|
|
|
|
|
